SEC Form 4 · accession 0001651844-15-000005

NYMOX PHARMACEUTICAL CORP · NYMX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Aug 21, 2015

Accepted (ET)

Sep 8, 2015 · 5:13 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001018735

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Aug 21, 2015	P	10,000	$2.19	A	2,177,550	D
Common Stock	Aug 21, 2015	P	10,000	$2.10	A	2,187,550	D
Common Stock	Aug 24, 2015	P	10,000	$2.15	A	2,197,550	D
Common Stock	Aug 26, 2015	P	10,000	$2.05	A	2,207,550	D
Common Stock	Aug 27, 2015	P	10,000	$2.11	A	2,217,550	D
Common Stock	Aug 28, 2015	P	10,000	$2.21	A	2,227,550	D
Common Stock	Aug 31, 2015	P	9,500	$2.34	A	2,237,050	D
Common Stock	Sep 1, 2015	P	4,100	$2.38	A	2,241,150	D
Common Stock	Sep 2, 2015	P	10,000	$2.45	A	2,251,150	D
Common Stock	Sep 3, 2015	P	16,400	$2.44	A	2,267,550	D
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust

No Table II lines on this filing.